Qube Research & Technologies LTD Ac Immune Sa Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Ac Immune Sa stock. As of the latest transaction made, Qube Research & Technologies LTD holds 48 shares of ACIU stock, worth $177. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48
Previous 48
-0.0%
Holding current value
$177
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ACIU
# of Institutions
48Shares Held
28.6MCall Options Held
163KPut Options Held
37.6K-
Bvf Inc San Francisco, CA18.8MShares$69.5 Million2.3% of portfolio
-
Black Rock Inc. New York, NY2.61MShares$9.62 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA1.81MShares$6.67 Million0.47% of portfolio
-
Wells Fargo & Company San Francisco, CA1.12MShares$4.14 Million0.0% of portfolio
-
Platinum Investment Management LTD Sydney Australia 2000, C3952KShares$3.51 Million0.16% of portfolio
About AC Immune SA
- Ticker ACIU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,413,504
- Market Cap $308M
- Description
- AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...